BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30878565)

  • 1. Navigating the landscape of core outcome set development in dermatology.
    Prinsen CAC; Spuls PI; Kottner J; Thomas KS; Apfelbacher C; Chalmers JR; Deckert S; Furue M; Gerbens L; Kirkham J; Simpson EL; Alam M; Balzer K; Beeckman D; Eleftheriadou V; Ezzedine K; Horbach SER; Ingram JR; Layton AM; Weller K; Wild T; Wolkerstorfer A; Williams HC; Schmitt J
    J Am Acad Dermatol; 2019 Jul; 81(1):297-305. PubMed ID: 30878565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative.
    Kottner J; Jacobi L; Hahnel E; Alam M; Balzer K; Beeckman D; Busard C; Chalmers J; Deckert S; Eleftheriadou V; Furlan K; Horbach SER; Kirkham J; Nast A; Spuls P; Thiboutot D; Thorlacius L; Weller K; Williams HC; Schmitt J;
    Br J Dermatol; 2018 Apr; 178(4):e279-e285. PubMed ID: 29441525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report from the kick-off meeting of the Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN).
    Schmitt J; Deckert S; Alam M; Apfelbacher C; Barbaric J; Bauer A; Chalmers J; Chosidow O; Delamere F; Doney E; Eleftheriadou V; Grainge M; Johannsen L; Kottner J; Le Cleach L; Mayer A; Pinart M; Prescott L; Prinsen CA; Ratib S; Schlager JG; Sharma M; Thomas KS; Weberschock T; Weller K; Werner RN; Wild T; Wilkes SR; Williams HC
    Br J Dermatol; 2016 Feb; 174(2):287-95. PubMed ID: 26779929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol of a scoping review of outcome domains in dermatology.
    Nadir U; Ahmed A; Yi MD; Hisham FI; Dave L; Kottner J; Ezzedine K; Garg A; Ingram JR; Jemec GBE; Spuls PI; Kirkham JJ; Cahn B; Alam M
    BMJ Open; 2024 Feb; 14(2):e079632. PubMed ID: 38320843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
    Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes for Pressure Ulcer Trials (OUTPUTs): protocol for the development of a core domain set for trials evaluating the clinical efficacy or effectiveness of pressure ulcer prevention interventions.
    Lechner A; Kottner J; Coleman S; Muir D; Bagley H; Beeckman D; Chaboyer W; Cuddigan J; Moore Z; Rutherford C; Schmitt J; Nixon J; Balzer K
    Trials; 2019 Jul; 20(1):449. PubMed ID: 31331366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochrane Reviews and Dermatological Trials Outcome Concordance: Why Core Outcome Sets Could Make Trial Results More Usable.
    Schmitt J; Lange T; Kottner J; Prinsen CAC; Weberschock T; Hahnel E; Apfelbacher C; Brandstetter S; Dreher A; Stevens G; Burden-Teh E; Rogers N; Spuls P; Grainge MJ; Williams HC; Jacobi L;
    J Invest Dermatol; 2019 May; 139(5):1045-1053. PubMed ID: 30528825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying common core outcome domains from core outcome sets of musculoskeletal conditions: protocol for a systematic review.
    Sabet TS; Anderson DB; Stubbs PW; Buchbinder R; Terwee CB; Chiarotto A; Gagnier J; Verhagen AP
    Syst Rev; 2022 Nov; 11(1):248. PubMed ID: 36403060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The standards of obstetrics and gynecology core outcome sets: A scoping review.
    Shi J; Gao Y; Wu S; Niu M; Chen Y; Yan M; Song Z; Feng H; Zhang J; Tian J
    Integr Med Res; 2022 Mar; 11(1):100776. PubMed ID: 34745879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core Outcome Sets Relevant to Maternity Service Users: A Scoping Review.
    Slavin V; Creedy DK; Gamble J
    J Midwifery Womens Health; 2021 Mar; 66(2):185-202. PubMed ID: 33565682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement was needed in the standards of development for cancer core outcome sets.
    Gargon E; Williamson PR; Blazeby JM; Kirkham JJ
    J Clin Epidemiol; 2019 Aug; 112():36-44. PubMed ID: 31009657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology.
    Schmitt J; Apfelbacher C; Spuls PI; Thomas KS; Simpson EL; Furue M; Chalmers J; Williams HC
    J Invest Dermatol; 2015 Jan; 135(1):24-30. PubMed ID: 25186228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvements and advances in core outcome set methodology: proceedings of the CS-COUSIN & COMFA Joint Meeting.
    Dirr MA; Alam M; Apfelbacher C; Drewitz KP; Kang BY; Munblit D; Nekliudov N; Seylanova N
    Arch Dermatol Res; 2023 Jul; 315(5):1375-1379. PubMed ID: 35244760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a core outcome set for clinical trials in facial aging: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Henley JK; Ashchyan HJ; Kurta AO; Patel PM; Sheikh UA; Franklin MJ; Hanna CC; Chen BR; Chiren SG; Schmitt J; Deckert S; Furlan KC; Poon E; Maher IA; Cartee TV; Sobanko JF; Alam M
    Trials; 2017 Aug; 18(1):359. PubMed ID: 28764734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for the development of core set of domains of the core outcome set for patients with congenital melanocytic naevi (OCOMEN project).
    Oei W; Fledderus AC; Korfage I; Eggen CAM; van der Horst CMAM; Spuls PI; Brinkmann SJH; Wolkerstorfer A; van Kessel M; Pasmans S
    J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):267-273. PubMed ID: 31419337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
    Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
    BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE).
    Healy P; Gordijn S; Ganzevoort W; Beune I; Baschat A; Khalil A; Kenny L; Bloomfield F; Daly M; Papageorghiou A; Devane D
    Trials; 2018 Aug; 19(1):451. PubMed ID: 30134949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA
    Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A core outcome set for all types of cardiac surgery effectiveness trials: a study protocol for an international eDelphi survey to achieve consensus on what to measure and the subsequent selection of measurement instruments.
    Moza A; Benstoem C; Autschbach R; Stoppe C; Goetzenich A
    Trials; 2015 Dec; 16():545. PubMed ID: 26625730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core outcomes in periodontal trials: study protocol for core outcome set development.
    Lamont TJ; Clarkson JE; Ricketts DNJ; Heasman PA; Ramsay CR
    Trials; 2017 Sep; 18(1):436. PubMed ID: 28931440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.